- Home
- BV vs SPRY Comparison
BV vs SPRY Comparison
Compare BV & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BV
- SPRY
- Stock Information
- Founded
- BV 1939
- SPRY 2015
- Country
- BV United States
- SPRY United States
- Employees
- BV N/A
- SPRY N/A
- Industry
- BV Business Services
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- BV Consumer Discretionary
- SPRY Health Care
- Exchange
- BV Nasdaq
- SPRY Nasdaq
- Market Cap
- BV 1.5B
- SPRY 1.4B
- IPO Year
- BV 2018
- SPRY N/A
- Fundamental
- Price
- BV $16.64
- SPRY $13.38
- Analyst Decision
- BV Buy
- SPRY Strong Buy
- Analyst Count
- BV 7
- SPRY 4
- Target Price
- BV $16.65
- SPRY $24.00
- AVG Volume (30 Days)
- BV 470.4K
- SPRY 1.3M
- Earning Date
- BV 11-13-2024
- SPRY 11-13-2024
- Dividend Yield
- BV N/A
- SPRY N/A
- EPS Growth
- BV N/A
- SPRY N/A
- EPS
- BV 0.20
- SPRY N/A
- Revenue
- BV $2,767,100,000.00
- SPRY $2,568,000.00
- Revenue This Year
- BV $4.33
- SPRY $21,686.67
- Revenue Next Year
- BV $3.01
- SPRY $956.61
- P/E Ratio
- BV $78.70
- SPRY N/A
- Revenue Growth
- BV N/A
- SPRY 8460.00
- 52 Week Low
- BV $7.29
- SPRY $4.65
- 52 Week High
- BV $18.89
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- BV 50.00
- SPRY 38.12
- Support Level
- BV $15.42
- SPRY $13.36
- Resistance Level
- BV $18.89
- SPRY $18.51
- Average True Range (ATR)
- BV 0.71
- SPRY 1.18
- MACD
- BV -0.23
- SPRY -0.33
- Stochastic Oscillator
- BV 42.16
- SPRY 6.73
About BV BrightView Holdings Inc.
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature, and the Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.